Anebulo Pharmaceuticals
ANEB
ANEB
9 hedge funds and large institutions have $27.5M invested in Anebulo Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
1
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.34K |
Top Sellers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$78.3K |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$16.8K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$16.5K |
| 4 |
BlackRock
New York
|
-$1.05K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
2L
1
22NW LP
Seattle,
Washington
| $21.9M | – | – | – |
|
|
MP
2
Mangrove Partners
Greenwich,
Connecticut
| $2.73M | -$78.3K | -11,954 | -3% |
|
|
LCM
3
Laurion Capital Management
New York
| $1.51M | – | – | – |
|
|
IC
4
Ikarian Capital
Dallas,
Texas
| $1.16M | -$16.8K | -2,502 | -1% |
|
|
BFM
5
Boothbay Fund Management
New York
| $114K | -$16.5K | -2,502 | -13% |
|
|
6
BlackRock
New York
| $50K | -$1.05K | -160 | -2% |
|
|
7
UBS Group
Zurich,
Switzerland
| $6K | +$4.34K | +614 | +262% |
|